Compliance in clinical trials, the oncology patient experience
- At: Seville (Spain) (2022)
- Type: Poster
- Poster code: HPS-062
- By: MARTíNEZ SOLER, Gema Inmaculada ()
- Co-author(s): Dr Eduardo Tejedor Tejada, Ph (Hospital Clinic Universitario, BARCELONA, Spain)
Mr DANIEL RUBIO CALVO, PHARMACY (Hospital de Poniente, Almeria, SPAIN)
Mrs Alba Martos Rosa, PHARMACY
Gema Inmaculada Martínez Soler (Hospital Clinic Universitario)
The degree of adherence and the effectiveness of treatments are directly related. In the case of clinical trials (CT), adherence plays a more important role since the objective is to evaluate the effectiveness of a new regimen or molecule.
The aim is to evaluate the compliance of the patient attending the oral medication.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019